1,371
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Increased physiological dead space at exercise is a marker of mild pulmonary or cardiovascular disease in dyspneic subjects

ORCID Icon &
Article: 1492842 | Received 08 Nov 2017, Accepted 20 Jun 2018, Published online: 05 Jul 2018

References

  • American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167:211–8.
  • Arena R, Sietsema KE. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation. 2011;123:668–680.
  • O’Donnell DE, Ora J, Webb KA, et al. Mechanisms of activity-related dyspnea in pulmonary diseases. Respir Physiol Neurobiol. 2009;167:116–132.
  • Flaherty KR, Wald J, Weisman IM, et al. Unexplained exertional limitation: characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med. 2001;164:425–432.
  • Wensel R, Opitz CF, Anker SD, et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation. 2002;106:319–324.
  • Balady GJ, Arena R, Sietsema K, et al. Clinician’s Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122:191–225.
  • Palange P, Ward SA, Carlsen KH, et al.; ERS Task Force. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29:185–209.
  • Wasserman K. Principles of exercise testing and interpretation: including pathophysiology and clinical applications. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
  • Markowitz DH, Systrom DM. Diagnosis of pulmonary vascular limit to exercise by cardiopulmonary exercise testing. J Heart Lung Transplant. 2004;23:88–95.
  • Belardinelli R, Lacalaprice F, Carle F, et al. Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing. Eur Heart J. 2003;24:1304–1313.
  • Held M, Grün M, Holl R, et al. Cardiopulmonary exercise testing to detect chronic thromboembolic pulmonary hypertension in patients with normal echocardiography. Respiration. 2014;87:379–387.
  • Petersson J, Glenny RW. Gas exchange and ventilation-perfusion relationships in the lung. Eur Respir J. 2014;44:1023–1041.
  • Moser M, Setaro JF. Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med. 2006;355:385–392.
  • Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J. 2005;26:153–161.
  • Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J Suppl. 1993;16:5–40.
  • Cotes JE, Chinn DJ, Quanjer PH, et al. Standardization of the measurement of transfer factor (diffusing capacity). Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J Suppl. 1993;16:41–52.
  • Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93:580–586.
  • Spiering BA, Judelson DA, Rundell KW. An evaluation of standardizing target ventilation for eucapnic voluntary hyperventilation using FEV1. J Asthma. 2004;41:745–749.
  • Cohen-Solal A, Laperche T, Morvan D, et al. Prolonged kinetics of recovery of oxygen consumption after maximal graded exercise in patients with chronic heart failure. Analysis with gas exchange measurements and NMR spectroscopy. Circulation. 1995;91:2924–2932.
  • Eng J ROC analysis: web-based calculator for ROC curves. Baltimore: Johns Hopkins University [Internet]. Johns Hopkins University; Available from: http://www.jrocfit.org.
  • Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.
  • Poggio R, Arazi HC, Giorgi M, et al. Prediction of severe cardiovascular events by VE/VCO2 slope versus peak VO2 in systolic heart failure: a meta-analysis of the published literature. Am. Heart J. 2010;160:1004–1014.
  • Gitt AK, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002;106:3079–3084.
  • Torchio R, Guglielmo M, Giardino R, et al. Exercise ventilatory inefficiency and mortality in patients with chronic obstructive pulmonary disease undergoing surgery for non-small-cell lung cancer. Eur J Cardio-Thorac Surg. 2010;38:14–19.
  • van der Plas MN, van Kan C, Blumenthal J, et al. Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis. Respirology. 2014;19:269–275.
  • Sun XG, Hansen JE, Oudiz RJ, et al. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation. 2001;104:429–435.
  • Schwaiblmair M, Faul C, von Scheidt W, et al. Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension. BMC Pulm Med. 2012;12:23.
  • Pappas GP, Newman LS. Early pulmonary physiologic abnormalities in beryllium disease. Am Rev Respir Dis. 1993;148:661–666.
  • Anderson SD, Silverman M, Walker SR. Metabolic and ventilatory changes in asthmatic patients during and after exercise. Thorax. 1972;27:718–725.
  • Hallstrand TS, Bates PW, Schoene RB. Aerobic conditioning in mild asthma decreases the hyperpnea of exercise and improves exercise and ventilatory capacity. Chest. 2000;118:1460–1469.
  • Feisal KA, Fuleihan FJ. Pulmonary gas exchange during exercise in young asthmatic patients. Thorax. 1979;34:393–396.
  • Martinez FJ, Stanopoulos I, Acero R, et al. Graded comprehensive cardiopulmonary exercise testing in the evaluation of dyspnea unexplained by routine evaluation. Chest. 1994;105:168–174.
  • Schmid A, Schilter D, Fengels I, et al. Design and validation of an interpretative strategy for cardiopulmonary exercise tests. Respirology. 2007;12:916–923.
  • Penicka M, Bartunek J, Trakalova H, et al. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis. J Am Coll Cardiol. 2010;55:1701–1710.
  • Scelsa SN, Yakubov B, Salzman SH. Dyspnea-fasciculation syndrome: early respiratory failure in ALS with minimal motor signs. Amyotroph Lateral Scler Mot Neuron Disord. 2002;3:239–243.
  • Hagman C, Janson C, Emtner M. Breathing retraining - a five-year follow-up of patients with dysfunctional breathing. Respir Med. 2011;105:1153–1159.
  • Han J, Zhu Y, Li S, et al. The language of medically unexplained dyspnea. Chest. 2008;133:961–968.
  • Wan L, Stans L, Bogaerts K, et al. Sensitization in medically unexplained dyspnea: differential effects on intensity and unpleasantness. Chest. 2012;141:989–995.
  • Robertson HT, Pellegrino R, Pini D, et al. Exercise response after rapid intravenous infusion of saline in healthy humans. J Appl Physiol. 2004;97:697–703.
  • Lewis BM. Measurement of arterial blood gases at the transition from exercise to rest. J Appl Physiol. 1983;54:1340–1344.
  • Topilsky Y, Hayes CL, Khanna AD, et al. Cardiopulmonary exercise test in patients with subacute pulmonary emboli. Heart Lung J Crit Care. 2012;41:125–136.